Last updated 6 days ago

A Study of (Neo)Adjuvant V940 and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)

1012 patients around the world
Available in Chile
Merck Sharp & Dohme LLC
5Research sites
1012Patients around the world

This study is for people with

Skin cancer
Cutaneous Squamous Cell Carcinoma

Requirements for the patient

From 18 Years
All Gender

Medical requirements

Sites

Sociedad de Beneficencia Hospital Italiano - Córdoba
Recruiting
Roma 550, Bº General Paz, Córdoba
Instituto Médico de la Fundación Estudios Clínicos - Rosario
Recruiting
Italia 428, Rosario - Santa Fe
James Lind Centro de Investigación del Cáncer - Temuco
Recruiting
Hochstetter 298, Temuco
CIDO SpA-Oncology
Recruiting
Temuco, Araucania, 4810218
Instituto Oncológico FALP - UIDO
Recruiting
José Manuel Infante 805, Providencia, Región Metropolitana
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy